ARPO Aerpio Pharmaceuticals Inc

DGAP-News: Planned EUR5 Billion Blockchain Eco-Enterprise Fights to Save the World

DGAP-News: Praestentia CleanTech / Key word(s): Miscellaneous
Planned EUR5 Billion Blockchain Eco-Enterprise Fights to Save the World

08.11.2018 / 09:14
The issuer is solely responsible for the content of this announcement.


  • Sustainability Funding of Up to €5 Billion Across 28 EU Member States and Just Over 280 EU Regions.
  • Best and Brightest Minds Carefully Vet Sustainability Technology Projects.
  • Blockchain-Powered Platform for Cleantech.

MELLIEHA, MALTA / ACCESSWIRE / November 8, 2018 / The Malta-based companies and - in partnership with - are embracing the progressive stance of 'Blockchain Island,' Malta. Together, they're on a mission to save the world.

Few organisations are positioned to achieve this goal. The marriage of blockchain and sustainability, however, is one of the ways new technology is solving traditional problems.

For over 15 years, leaders in Paragon Europe have been helping sustainability projects get funded and see the light of day. Now it's time to take this work to a global scale through a partnership with the BDXAlliance.

Imagine sustainability funding of €5 billion across 28 EU Member States and just over 280 . Imagine the best and brightest minds carefully vetting transformative sustainability technology projects. The outcome is to tap into a major €5bn initiative to save the world through the highest quality technical initiatives.

Dr. Anton Theuma and Edwin Ward, CEO and Chairman respectively of Praestentia CleanTech said, 'Praestentia CleanTech was launched in October 2018 to fight to save the world and create a B2B and B2C cleantech marketplace, marketing directly to source at low cost. For many years we've been on a mission to leave the planet better than we found it. Our desire has always been to go global with our work. Now, partnering with BDXAlliance, we can create the world's largest community who also want to save the world. Long-term, our community will have access to debit and credit cards that provide reward points. Our Community Members will have banking-style services backed by a Membership and Loyalty Program that will be the most flexible in the world. The shared projects will have shared benefits across them. All our organisations think globally and want to save the world, with a strategy that combines blockchain technology with sustainability in smart ways to make a difference.'

Jamy Nigri, CEO of BDXAlliance, said, 'Together we're applying everything we've learned over the last few decades to help save the world. We know the clock is ticking, and if we don't make meaningful change in the next ten years, we may lose a very important window to do good. Rarely in life does one get to come to work every day and be passionate about making the world better. We have that privilege. We get to do good every day.'

For interviews, images and further information, please contact

Robert White, BDXAlliance
Mobile/WhatsApp:
Telegram: @robertbdx
Email:

About

Praestentia CleanTech is the world's first blockchain platform for clean technology with a mission to create and set up a clean marketplace. The aim is to improve trading, knowledge and innovation in the cleantech field, which is growing into a €Trillion sector economy. We will create several trading platforms built on the best practice models, such as Amazon, Facebook and YouTube. The world needs a cleantech marketplace, and we are ready to provide it, helping to create a clean future for everyone.

About

BDXAlliance is a cryptocurrency ecosystem of blockchain-connected businesses. We are applying to be licensed and regulated by the Malta Financial Services Authority (MFSA). We're going to make blockchain and cryptocurrency available for everyday use by customers. How? By offering them a comprehensive set of products and services that will be easy to use. We'll also provide services for companies that want to launch their own ICOs. Our products and services will include: Exchange with our native coin, an integrated ICO platform to curate and support carefully chosen ICOs, an OTC desk for large-scale transactions, a wallet with integrated portfolio management, enterprise-grade Know Your Customer (KYC) software, an App, and a full-service Virtual Financial Asset agency for the licensing of ICOs. Because we believe education is vital for customers to make informed decisions about the use of cryptocurrencies and blockchain, we will also provide excellent educational classes.

About

Paragon Europe is a regional development company with its HQ in Malta and a representation office in Brussels. Paragon Europe leads and coordinates projects across the EU and is a trusted partner of EU institutions. Paragon Europe is also the national contact point for Climate-KIC, the Water Cluster, the Digital Cluster and is Malta's representative to MEDENER, the EU's partner on energy efficiency and renewables in the Mediterranean. In projects and tenders, Paragon Europe works in partnership with advisory firms, research and technology organisations, regional and local authorities and non-profit organisations, bringing in its expertise in implementing business and financial plans, communication campaigns, stakeholder engagement and outreach activities, feasibility and pre-deployment studies, climate impact assessments, socio-economic impact evaluations and pilot facilities to demonstrate the innovation potential of new solutions.

Active in CSR Europe, Paragon Europe also partners with European and American educational institutes and agencies acting as a port of call for learning mobility programmes in Malta and Brussels. The full cycle of the mobility is managed internally, from logistics to professional training and language tuition.

SOURCE: Agility PR Solutions



08.11.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at


Language: English
Company: Praestentia CleanTech
United States

 
End of News DGAP News Service

743019  08.11.2018 

fncls.ssp?fn=show_t_gif&application_id=743019&application_name=news&site_id=research_pool
EN
08/11/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Aerpio Pharmaceuticals Inc

 PRESS RELEASE

Aadi Bioscience to Join Russell 2000® and Russell 3000® Indexes

Aadi Bioscience to Join Russell 2000® and Russell 3000® Indexes LOS ANGELES, June 23, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, today announced it will join both the U.S. small cap Russell 2000® Index and broad-market Russell 3000® Index at the conclusion of the 2022 Russell indexes annual reconstitution, effective immediately after the U.S. market opens on June 24, 2022 according to a preliminary list of add...

 PRESS RELEASE

Aadi Bioscience to Present at the Jefferies Global Healthcare Conferen...

Aadi Bioscience to Present at the Jefferies Global Healthcare Conference LOS ANGELES, June 01, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, today announced members of the Aadi senior management team will participate in the Jefferies Global Healthcare Conference, to be held in New York, NY June 8-10, 2022. Founder, Chief Executive Officer and President, Neil Desai, Ph.D. is scheduled to present live during a fire...

 PRESS RELEASE

Aadi Bioscience Appoints Marcy Graham Senior Vice President Investor R...

Aadi Bioscience Appoints Marcy Graham Senior Vice President Investor Relations and Corporate Communications LOS ANGELES, May 31, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, today announced the appointment of Marcy Graham to the new position of Senior Vice President, Investor Relations (IR) and Corporate Communications. “We are delighted to welcome Marcy to the team, as she brings extensive experience to ...

 PRESS RELEASE

Aadi Bioscience Announces Exploratory Biomarker Data from Patients in ...

Aadi Bioscience Announces Exploratory Biomarker Data from Patients in Its AMPECT Trial and Expanded Access Program to be Presented at 2022 ASCO Annual Meeting Target tumor reductions observed in advanced malignant PEComa patients harboring TSC1 or TSC2 inactivating alterations regardless of prior mTOR inhibitor exposure LOS ANGELES, May 26, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, today announced presentat...

 PRESS RELEASE

Aadi Bioscience to Present at the H.C. Wainwright Global Investment Co...

Aadi Bioscience to Present at the H.C. Wainwright Global Investment Conference LOS ANGELES, May 18, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (Nasdaq: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced that Founder, Chief Executive Officer and President, Neil Desai, Ph.D., and senior members of Aadi’s executive team will participate virtually in the H.C. Wainwright Global Investment Conference, to be held in person and virtually May 23-26, 2022 in Mia...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch